Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019
April 02 2019 - 7:00AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company which uses its “Trait Factory” to develop high value seed
traits for the agriculture and food industries, today announced
that Oliver Peoples, Ph.D., president and chief executive officer
of Yield10 will present at the Advanced Bioeconomy Leadership
Conference (ABLC) 2019 held April 3-5 at the Mayflower Marriott
Hotel in Washington, D.C.
Dr. Peoples’ presentation is titled “The Yield10 Trait Factory:
Deploying Knowledge Gained from Industrial Biotech with
Genome-editing to Increase Crop Yield” and will take place on the
ABLC Advanced Nutrition & Bioeconomy Feedstocks and Supply
Chain track in a panel entitled “Advanced Yields through
Technology” on Wednesday April 3, 2019 at 12:40 p.m. Eastern
Time.
Dr. Peoples will describe the approaches Yield10 is taking to
increase seed yield, oil content and biomass in crops. He will also
highlight the Company’s GRAIN technology platform and provide an
overview of traits in development by Yield10, including traits
potentially accessible through genome-editing and applicable to
major crops including canola, corn, soybean, wheat and
rice.
The ABLC conference hosts professionals in policy, finance,
partnerships, world class R&D and effective scale-up, spanning
major agricultural companies, heads of all the top agricultural
trade associations, and key government agencies. The keynote
speaker is Hon. Sonny Perdue, the 31st US Secretary of Agriculture.
Learn more about the conference at the Advanced Bioeconomy
Leadership Conference 2019 website. Following the presentation, a
copy of Dr. Peoples’ slide deck will be available on the Yield10
Bioscience website.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
which uses its “Trait Factory” to develop high value seed traits
for the agriculture and food industries to achieve step-change
improvements in crop yield to enhance global food security. Yield10
has an extensive track record of innovation based around optimizing
the flow of carbon in living systems. The “Trait Factory” has two
components: the “GRAIN” computational modeling platform, which is
used to identify specific gene changes designed to improve crop
performance, and the deployment of those changes into crops using
genome-editing or traditional agricultural biotechnology
approaches. The purpose of the “Trait Factory” is to engineer
precise alterations to gene activity and the flow of carbon in
plants to produce higher yields with lower inputs of land, water or
fertilizer. Yield10 is advancing several yield traits it has
developed in crops such as canola, soybean, rice, wheat and corn.
Yield10 is headquartered in Woburn, MA and has an Oilseeds Center
of Excellence in Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, the use of the Company’s technology to successfully
identify targets and develop systems for increasing crop yield and
the progress toward developing yield traits in crops by Yield10,
constitute forward-looking statements. Such forward-looking
statements are subject to a number of risks and uncertainties that
could cause actual results to differ materially from those
anticipated, including the risks and uncertainties detailed in
Yield10 Bioscience's filings with the Securities and Exchange
Commission. Yield10 assumes no obligation to update any
forward-looking information contained in this press release or with
respect to the matters described herein.
Contacts: Yield10
Bioscience: Lynne H. Brum, (617) 682-4693,
LBrum@yield10bio.com
Investor Relations: Bret Shapiro, 561-479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
Marketing and PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2024 to May 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From May 2023 to May 2024